Takeda To Help Develop Lundbeck’s First-In-Class Mood Disorder Candidates In Japan, U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal includes $40 million upfront payment and potential $345 million in milestones for Lundbeck.